The effect of chemotherapy on programmed cell death 1/ programmed cell death 1 ligand axis: Some chemotherapeutical drugs may finally work through immune response

22Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Most tumors are immunogenic which would trigger some immune response. Chemotherapy also has immune potentiating mechanisms of action. But it is unknown whether the immune response is associated with the efficacy of chemotherapy and the development of chemoresistance. Recently, there is a growing interest in immunotherapy, among which the co-inhibitory molecules, programmed cell death 1/programmed cell death 1 ligand (PD-1/PD-L1) leads to immune evasion. Since some reports showed that conventional chemotherapeutics can induce the expression of PD-L1, we try to summarize the effect of chemotherapy on PD-1/PD-L1 axis and some potential molecules relevant to PD-1/PD-L1 in chemoresistance in this review.

Cite

CITATION STYLE

APA

Luo, M., & Fu, L. (2016). The effect of chemotherapy on programmed cell death 1/ programmed cell death 1 ligand axis: Some chemotherapeutical drugs may finally work through immune response. Oncotarget, 7(20), 29794–29803. https://doi.org/10.18632/oncotarget.7631

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free